Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 06, 2023

Semaglutide for Weight Loss in Patients With Severe Obesity With or Without a History of Bariatric Surgery



Additional Info

Disclosure statements are available on the authors' profiles:

Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery
Obesity 2023 Nov 05;[EPub Ahead of Print], JB Bonnet, S Tournayre, J Anitcheou, M Faivre, C Boegner, A Jalek, D Jullien, V Attalin, J Myzia, L Marty, Y Kemba, D Nocca, A Sultan, A Avignon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading